Introduction: In hyperthyroidism, selective irradiation of the thyroid gland with radioactive iodine is a radical treatment and an alternative to surgery. The aim of this review is to assess the medium-term efficacy of outpatient treatment of hyperthyroidism with iodine-131 in Africa. Methods: We identified the studies carried out in Africa on outpatient radiation therapy between 2016 and 2020. For each article included, we noted the country concerned and the year of publication, the numbers studied, the socio-demographic characteristics of the patients, the indications for radio iodine therapy, the dose administered, the results of the hormonal dosage 6 months after radiation. Results: 13 retrospective studies were included to constitute a total population of 925 patients. The average age was 40.77 years, the sex ratio of 1/5.4 with a clear female predominance. The 3 main etiologies of hyperthyroidism justifying outpatient radio iodine therapy were Graves’ disease (55.89%), toxic multinodular goiter (22.70%) and toxic adenoma (21.40%). The average dose of iodine 131 administered per course is 13.7 mCi. No short-and medium-term complications were reported. The radio iodine therapy was effective in 86.08% (n = 796) of the patients with extremes of 72% and 100%. Conclusion: Radio iodine therapy is effective in Africa. It is simple, inexpensive on an outpatient basis and well tolerated. The introduction of outpatient radio iodine therapy could improve the management of patients with hyperthyroidism in Burkina Faso.
References
[1]
Ogbera, A.O. and Kuku, S.F. (2011) Epidemiology of Thyroid Diseases in Africa. Indian Journal of Endocrinology and Metabolism, 15, 82-88. https://doi.org/10.4103/2230-8210.83331
[2]
Hertz, B.E. and Schuller, K.E. (2010) A Pioneer in the Use of Radioactive Iodine. Endocrine Practice, 16, 713-715. https://doi.org/10.4158/EP10065.CO
[3]
Burch, H.B. and Cooper, D.S. (2015) Management of Graves’ Disease: A Review. JAMA, 314, 2544-2554. https://doi.org/10.1001/jama.2015.16535
[4]
Rezgani Chelbi, I., Meddeb, I., Yeddeas, I., Limam, K., et al. (2016) La maladie de Basedow chez l’enfant: Placede l’irathérapie. Annales d’Endocrinologie, 77, 390. https://doi.org/10.1016/j.ando.2016.07.455
[5]
Yetunde, A., Ankrah, A. and Adedapo, K.S. (2016) Outcome of Radioiodine Therapy in a West African Population. World Journal of Nuclear Medicine, 15, 24-29. https://doi.org/10.4103/1450-1147.167585
[6]
Ben Souda, M., Marhari, H., Fokoue, F., Salhi, H., El Ouahabi, H. and Alaoui, N. (2018) Place de l’irathérapie dans le traitement de la maladie de Basedow: A propos de 50 cas. Annals of Endocrinology, 79, 359. https://doi.org/10.1016/j.ando.2018.06.512
[7]
Aschawa, H., Touil, S., Shimi, Y., Bendaoud, H., Meftah, S. and Aaouini, R. (2017) Hyperthyroidism: Short-Term Efficacy of Radioactive Iodine Treatment. Moroccan Journal of Public Health, 4, 7-12.
[8]
El Feleh, E., Mahjoubi, S., Bachir, N., Jaidane, A., Sellemb, A. and Ouertani, H. (2017) Place of Radio Iodine Therapy in the Treatment of Graves’ Disease. Annals of Endocrinology, 78, 326. https://doi.org/10.1016/j.ando.2017.07.352
[9]
Rezgani, I., Meddeb, I., Yeddeas, I., Slim, I., Mhiri, A. and Ben Slimène, M.F. (2017) Comparative Study of the Efficacy of IRA Therapy in Graves’ Disease and Toxic Thyroid Nodules. Annals of Endocrinology, 78, 337. https://doi.org/10.1016/j.ando.2017.07.390
[10]
Choukry, S., Benouhoud, J., Choukry, K., Aschawa, H. and Guensi, A. (2018) évolution des maladies de Basedow après irathérapie (à propos de 78 cas). Médecine Nucléaire, 42, 164. https://doi.org/10.1016/j.mednuc.2018.03.083
[11]
Nwatsock, J.F., Mbeng, A.V. and Dong-à-Zok, F. (2019) Indications et efficacité à 6 Mois de l’Irathérapie à activité ablative fixe dans l’hyperthyroïdie à Yaoundé. Health Sciences and Disease, 20, 31-36. https://www.hsd-fmsb.org/index.php/hsd/article/view/1644
[12]
Bounab, T., Ghennam, B., Zitouni, I.M., et al. (2019) Traitement de la maladie de Basedow chez l’enfant par l’iode 131: à propos de deux cas. Médecine Nucléaire, 43, 198. https://doi.org/10.1016/j.mednuc.2019.01.073
[13]
Fokoue, F., El Mselmi, S. and Ismaili, A.N. (2019) Epidemiological Profile and Therapeutic Efficacy of Iodine 131 in the Management of Hyperthyroidism: About 208 Patients. Nuclear Medicine, 43, 199. https://doi.org/10.1016/j.mednuc.2019.01.076
[14]
Bathily, E.H.A.L., et al. (2020) Traitement des hyperthyroïdies par l’iode 131: Bilan d’activité préliminaire du service de médecine nucléaire de l’hôpital général de Grand Yoff de Dakar. Médecine Nucléaire, 44, 130-131. https://www.sciencedirect.com/science/article/pii/S0928125820300917 https://doi.org/10.1016/j.mednuc.2020.01.075
[15]
Grassa, A., Jemel, M., Salhi, S., Kandara, H., Khemiri, M. and Kammoun, I. (2020) Graves’ Disease Treated with Radiation Therapy: Indication and Therapeutic Response. Annals of Endocrinology, 81, 345. https://doi.org/10.1016/j.ando.2020.07.575
[16]
Sellem, A., Elajmi, W., Ben Mhamed, R., Oueslati, N., Ouertani, H. and Hammami, H. (2020) Role and Effectiveness of Radioactive-Iodine Therapy for the Treatment of Grave’s Disease. The Pan African Medical Journal, 36, Article 341. https://doi.org/10.11604/pamj.2020.36.341.21623
[17]
Colombet, I. (2015) Revue systématique et méta-analyse en médecine palliative, Médecine Palliative. Médecine Palliative: Soins de Support-Accompagnement-éthique, 14, 240-253. https://doi.org/10.1016/j.medpal.2015.04.001 https://www.sciencedirect.com/science/article/pii/S1636652215000380
[18]
Onimode, Y.A., Magbagbeola, D. and Ellmann, A. (2018) Pattern of Presentation of Graves’ Disease and Response to Radioiodine Therapy in South African Men. Pan African Medical Journal, 29, Article 48. https://doi.org/10.11604/pamj.2018.29.48.13655
[19]
SFMN: French Society of Nuclear Medicine (2021) Guide for Writing Treatment Protocols for Hyperthyroidism with Iodine 131. https://www.cnp-mn.fr/wp-content/uploads/2022/09/Traitement-hyperthyroidie-V1.0.pdf
[20]
Borson-Chazot, F., Caron, P., Glinoer, D. and Wémeau, J.L. (2014) Synthetic Antithyroid Drugs: What to Choose? La Presse Médicale, 43, 105-108. https://doi.org/10.1016/j.lpm.2014.01.003
